다우존스 지수

브라질 증권 거래소, NASDAQ, NYSE, AMEX, LSE 등 주요 거래소에서의 다양한 실시간 주식 시세를 모니터링합니다.

등록

홈
인베스팅
주식
미국
NASDAQ
Stealth BioTherapeutics Corporation (MITO)
Stealth BioTherapeutics Corporation (MITO) 뉴스

MITO

Stealth BioTherapeutics (MITO)

Stealth BioTherapeutics Corporation

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:MITO

1 2 3 4 5 6 7 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2022/11/29	08:41	Edgar (US Regulatory)	Termination of Registration of a Class of Security Under Section 12(g) (15-12g)	NASDAQ:MITO	Stealth BioTherapeutics Corporation
2022/11/17	06:23	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	NASDAQ:MITO	Stealth BioTherapeutics Corporation
2022/11/17	06:22	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	NASDAQ:MITO	Stealth BioTherapeutics Corporation
2022/11/17	06:20	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	NASDAQ:MITO	Stealth BioTherapeutics Corporation
2022/11/17	06:19	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	NASDAQ:MITO	Stealth BioTherapeutics Corporation
2022/11/17	06:16	Edgar (US Regulatory)	Post-effective Amendment to Registration Statement (pos Am)	NASDAQ:MITO	Stealth BioTherapeutics Corporation
2022/11/17	06:14	Edgar (US Regulatory)	Post-effective Amendment to Registration Statement (pos Am)	NASDAQ:MITO	Stealth BioTherapeutics Corporation
2022/11/17	06:10	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:MITO	Stealth BioTherapeutics Corporation
2022/11/17	06:08	Edgar (US Regulatory)	Amended Statement of Ownership: Private Transaction (sc 13e3/a)	NASDAQ:MITO	Stealth BioTherapeutics Corporation
2022/11/17	06:01	PR Newswire (US)	Stealth BioTherapeutics Corp Announces Completion of Merger	NASDAQ:MITO	Stealth BioTherapeutics Corporation
2022/11/01	20:30	PR Newswire (US)	Stealth BioTherapeutics Announces SBT-272 Data Updates and Orphan Drug Designation for the Treatment of Amyotrophic Lateral Sclerosis (ALS)	NASDAQ:MITO	Stealth BioTherapeutics Corporation
2022/10/08	05:01	PR Newswire (US)	Stealth BioTherapeutics Corp to Hold Extraordinary General Meeting of Shareholders	NASDAQ:MITO	Stealth BioTherapeutics Corporation
2022/10/01	06:01	TipRanks	Stealth Biotherapeutics announces resignation of CFO Robert Weiskopf	NASDAQ:MITO	Stealth BioTherapeutics Corporation
2022/10/01	06:00	PR Newswire (US)	Stealth BioTherapeutics Announces Departure of Chief Financial Officer	NASDAQ:MITO	Stealth BioTherapeutics Corporation
2022/09/24	06:21	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (sc 13d/a)	NASDAQ:MITO	Stealth BioTherapeutics Corporation
2022/09/16	05:45	PR Newswire (US)	Stealth BioTherapeutics to Participate in Upcoming Ultra-Rare Disease Events	NASDAQ:MITO	Stealth BioTherapeutics Corporation
2022/08/20	05:16	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:MITO	Stealth BioTherapeutics Corporation
2022/08/19	22:50	Edgar (US Regulatory)	Statement of Ownership: Private Transaction (sc 13e3)	NASDAQ:MITO	Stealth BioTherapeutics Corporation
2022/08/02	05:46	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (sc 13d/a)	NASDAQ:MITO	Stealth BioTherapeutics Corporation
2022/08/01	22:48	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:MITO	Stealth BioTherapeutics Corporation
2022/08/01	21:30	PR Newswire (US)	Stealth BioTherapeutics Corp Enters Definitive Agreement for Going Private Transaction	NASDAQ:MITO	Stealth BioTherapeutics Corporation
2022/07/12	06:21	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:MITO	Stealth BioTherapeutics Corporation
2022/07/12	06:15	PR Newswire (US)	STEALTH BIOTHERAPEUTICS ANNOUNCES RECEIPT OF NON-COMPLIANCE NOTICE FROM NASDAQ	NASDAQ:MITO	Stealth BioTherapeutics Corporation
2022/06/28	05:50	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (sc 13d/a)	NASDAQ:MITO	Stealth BioTherapeutics Corporation
2022/06/27	23:25	AllPennyStocks.com	Premarket Indicating Higher Open For This Biotech	NASDAQ:MITO	Stealth BioTherapeutics Corporation
2022/06/27	21:02	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:MITO	Stealth BioTherapeutics Corporation
2022/06/27	20:30	PR Newswire (US)	Stealth BioTherapeutics Corp Announces Receipt of Preliminary Non-Binding Proposal	NASDAQ:MITO	Stealth BioTherapeutics Corporation
2022/06/16	19:15	TipRanks	H.C. Wainwright Thinks Stealth Biotherapeutics’ Stock is Going to Recover	NASDAQ:MITO	Stealth BioTherapeutics Corporation
2022/06/16	19:05	Edgar (US Regulatory)	Notice of Effectiveness (effect)	NASDAQ:MITO	Stealth BioTherapeutics Corporation
2022/06/14	20:25	PR Newswire (US)	Stealth BioTherapeutics Granted Pre-NDA Meeting for Elamipretide as a Potential Treatment for Barth Syndrome	NASDAQ:MITO	Stealth BioTherapeutics Corporation

검색 관련기사 보기:NASDAQ:MITO

1 2 3 4 5 6 7 다음 >>

Aston Martin Fp

Frontier Acquisition

Dimensional Internationa...

Aristotle Value Equity F...

AI Robotics & Technology...

VinaCapital Vietnam Oppo...

Adm Asia Secured Lending...

Vontobel Financial Produ...

iShares Global Consumer ...

Lionheart Acquisition Co...

LooksRare Token

GigInternational1

Dividend Strength Opport...

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관